Home LiteratureArticle Details
PMID: 6352490 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.

Infection and immunity ·Vol. 42 ·No. 1 ·1983-10-00 ·Pages 141-51

Yeung MK, Mattingly SJ

Abstract

Four classes of mutants of type III group B streptococcus were isolated by serial subculture of the wild-type strain in the presence of type III-specific rabbit antiserum. Class I mutants no longer synthesized sialic acid but still elaborated the core antigen. Class II mutants maintained the ability to synthesize sialic acid but could not attach it to the core antigen. Class III mutants did not produce the core antigen but still synthesized intracellular sialic acid. Class IV mutants synthesized the complete antigen; however, only approximately 4% of the antigen synthesized was found associated with the cell wall peptidoglycan (in the wild-type strain greater than 85% of the antigen synthesized is covalently attached to the cell wall peptidoglycan), whereas greater than 90% of the antigen was secreted into the growth medium. Production of other components (CAMP factor, group B antigen, beta-hemolysin, neuraminidase) by these mutants appeared similar to those of the wild-type strain. Mouse lethality studies of these strains indicated that all four classes have greater than 3 log10-higher 50% lethal dose values than that of the wild-type strain. To understand the basis for this variation, the invasive ability of the wild-type strain and the sialic acid-deficient mutant strain M-10 (class I) was examined. Mice received 10(5) CFU of each organism; they were then sacrificed at various times postinoculation, and viable group B streptococci from different organs were enumerated. Mice were able to clear M-10 more efficiently, with greater than 80% of M-10 cells being phagocytized by macrophages within 1 h, whereas the wild-type strain was able to evade phagocytic killing and disseminate to other tissues. These data, therefore, strongly indicate that the sialic acid moiety greatly enhances the virulence of the type III antigen. In addition, the level of cell-associated type-specific antigen appears to contribute significantly to the pathogenicity of the organism.

MeSH Terms
Animals Antigens, Bacterial Antigens, Surface Lethal Dose 50 Macrophages/immunology Mice Mutation Sialic Acids/physiology Streptococcus agalactiae/genetics,immunology,pathogenicity Virulence
Chemicals
Antigens, Bacterial Antigens, Surface Sialic Acids
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Yeung M K
Mattingly S J
References (41)
41 references, click to expand
  1. The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.
    J Exp Med. 1969 Jun 1;129(6):1275-90 PMID: 4181833
  2. Electrophoretic mobility and N-acetyl neuraminic acid content of human normal and leukemic lymphocytes and granulocytes.
    Blood. 1970 Jan;35(1):12-22 PMID: 5412671
  3. Physical and chemical studies on ceruloplasmin. IX. The role of galactosyl residues in the clearance of ceruloplasmin from the circulation.
    J Biol Chem. 1970 Sep 10;245(17):4397-402 PMID: 4322435
  4. The role of sialic acid in determining the survival of glycoproteins in the circulation.
    J Biol Chem. 1971 Mar 10;246(5):1461-7 PMID: 5545089
  5. Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide.
    J Biol Chem. 1971 Aug 10;246(15):4703-12 PMID: 4327325
  6. The binding of desialylated glycoproteins by plasma membranes of rat liver.
    J Biol Chem. 1971 Aug 10;246(15):4825-33 PMID: 4327329
  7. Factors involved in the cytotoxicity of normal guinea pig serum for cells of murine tumor TA3 sublines treated with neuraminidase.
    J Immunol. 1973 Oct;111(4):1071-80 PMID: 4728677
  8. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.
    N Engl J Med. 1974 May 30;290(22):1216-20 PMID: 4133095
  9. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins.
    Adv Enzymol Relat Areas Mol Biol. 1974;41(0):99-128 PMID: 4609051
  10. Growth of several cariogenic strains of oral streptococci in a chemically defined medium.
    Infect Immun. 1975 Apr;11(4):649-55 PMID: 1091546
  11. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Lab Invest. 1975 Apr;32(4):476-84 PMID: 1127870
  12. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.
    J Exp Med. 1975 Jul 1;142(1):165-79 PMID: 1097573
  13. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
    Pediatr Res. 1976 Feb;10(2):82-7 PMID: 1107953
  14. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
    J Clin Invest. 1976 Dec;58(6):1379-87 PMID: 62761
  15. Effect of sialidase on the viability of erythrocytes in circulation.
    Am J Hematol. 1976;1(4):419-32 PMID: 1008055
  16. Phagocytosis as a surface phenomenon.
    Annu Rev Microbiol. 1978;32:19-39 PMID: 360965
  17. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.
    Infect Immun. 1978 Sep;21(3):738-46 PMID: 361576
  18. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.
    J Immunol. 1979 Jan;122(1):75-81 PMID: 762425
  19. Immunodeterminant specificity of human immunity to type III group B streptococcus.
    J Exp Med. 1979 Feb 1;149(2):327-39 PMID: 84042
  20. Electron microscopic definition of surface antigens of group B Streptococcus.
    J Infect Dis. 1979 Feb;139(2):147-51 PMID: 374641
  21. Soluble group- and type-specific antigens from type III group B Streptococcus.
    Infect Immun. 1980 Apr;28(1):195-203 PMID: 6155346
  22. Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus.
    Can J Biochem. 1980 Feb;58(2):112-20 PMID: 6155983
  23. Factors influencing release of type III antigens by group B streptococci.
    Infect Immun. 1981 Feb;31(2):615-23 PMID: 7012015
  24. Properties of a hemolysin produced by group B streptococci.
    Infect Immun. 1980 Dec;30(3):805-13 PMID: 7014450
  25. Activation of the alternative complement pathway by enveloped viruses containing limited amounts of sialic acid.
    Virology. 1981 Oct 30;114(2):507-15 PMID: 6270885
  26. Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.
    Br J Exp Pathol. 1981 Aug;62(4):393-7 PMID: 7028073
  27. Variations in the opsonic requirements of group B streptococcus type III.
    Br J Exp Pathol. 1981 Oct;62(5):519-25 PMID: 7028075
  28. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.
    Infect Immun. 1981 Nov;34(2):448-54 PMID: 7030959
  29. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
    Pediatr Res. 1981 Dec;15(12):1525-9 PMID: 7033908
  30. Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis.
    Infect Immun. 1982 Feb;35(2):572-81 PMID: 7035367
  31. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
    J Immunol. 1982 Mar;128(3):1278-83 PMID: 7035562
  32. Partial removal of sialic acid enhances phagocytosis and the generation of superoxide and chemiluminescence by polymorphonuclear leukocytes.
    J Immunol. 1982 Aug;129(2):745-50 PMID: 6282969
  33. Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.
    Infect Immun. 1982 Jun;36(3):1115-22 PMID: 7047392
  34. Biosynthesis of cell wall peptidoglycan and polysaccharide antigens by protoplasts of type III group B Streptococcus.
    J Bacteriol. 1983 Apr;154(1):211-20 PMID: 6339471
  35. Colominic acid, a polymer of N-acetylneuraminic acid.
    J Exp Med. 1958 Apr 1;107(4):507-21 PMID: 13513915
  36. The biosynthesis of cytidine 5'-monophospho-n-acetylneuraminic acid by an enzyme from Neisseria meningitidis.
    J Biol Chem. 1962 Nov;237:3527-34 PMID: 13998986
  37. ANTIGENIC RELATIONSHIPS BETWEEN GROUPS B AND G STREPTOCOCCI.
    J Exp Med. 1964 Oct 1;120:629-37 PMID: 14212124
  38. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids.
    Biochem J. 1961 Nov;81:384-92 PMID: 13860975
  39. An alteration in tumor histocompatibility induced by neuraminidase.
    Transplantation. 1967 Sep 5;5(5):1273-9 PMID: 6056941
  40. Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo.
    J Biol Chem. 1968 Jan 10;243(1):155-9 PMID: 5635941
  41. The effect of neuraminidase on the fate of transfused lymphocytes.
    J Exp Med. 1969 Mar 1;129(3):551-67 PMID: 5766942
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1983-10-00
Pages
141-51
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC264535
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]